BTS
GWPH

BB&T Securities’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

BB&T Securities’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,445
Closed -$249K – 1643
2018
Q3 		$249K Buy
+1,445
New +$208K ﹤0.01% 1391

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
SCM
Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BB&T Securities's GWPH Position: Q4 2018 in Review

BB&T Securities sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 1,445 shares — an estimated $249K sold.

BB&T Securities first reported a position in GWPH in Q3 2018 and held it in 1 quarter. The position peaked at $249K in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • BB&T Securities reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • BB&T Securities sold 1,445 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $249K.
  • BB&T Securities first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 1 quarter.
  • BB&T Securities's GW Pharmaceuticals Plc American Depositary Shares position peaked at $249K in Q3 2018.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on BB&T Securities's 13F filing for Q4 2018, filed 4 Feb 2019.